Lv6
1740 积分 2023-02-02 加入
Antibody–drug conjugates for cancer
2小时前
已完结
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
8小时前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
17天前
已完结
Impact of Tumor Assessment Frequency on Statistical Power in Randomized Cancer Clinical Trials Evaluating Progression-Free Survival
20天前
已完结
Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
21天前
已完结
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
21天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
21天前
已完结
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
21天前
已完结
Identifying the genomic landscape of EGFR-mutant lung cancers with CNS metastases
21天前
已完结
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
21天前
已完结
皖公网安备34019202002308
